| A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) (NCT03158103) | Memorial Sloan Kettering Cancer Center | 2017-04-15 |
| Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma (NCT03120676) | Memorial Sloan Kettering Cancer Center | 2017-04-14 |
| Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant (NCT03116997) | Memorial Sloan Kettering Cancer Center | 2017-04-07 |
| A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis (NCT03127709) | Memorial Sloan Kettering Cancer Center | 2017-04-07 |
| Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells (NCT03107416) | Memorial Sloan Kettering Cancer Center | 2017-04-05 |
| Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors (NCT03114566) | Memorial Sloan Kettering Cancer Center | 2017-04-05 |
| Imaging With a New Agent That Finds a Cancer Protein Called HER2 (NCT03109977) | Memorial Sloan Kettering Cancer Center | 2017-03-31 |
| Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer (NCT03056638) | Memorial Sloan Kettering Cancer Center | 2017-03-28 |
| A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer (NCT03093922) | Memorial Sloan Kettering Cancer Center | 2017-03-22 |
| Adaptive Radiotherapy for Head and Neck Cancer (NCT03096808) | Memorial Sloan Kettering Cancer Center | 2017-03-15 |
| A Dye for the Detection of Cancer of the Tongue and Mouth (NCT03085147) | Memorial Sloan Kettering Cancer Center | 2017-03-15 |
| Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer (NCT03085056) | Memorial Sloan Kettering Cancer Center | 2017-03-15 |
| A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies (NCT03085173) | Memorial Sloan Kettering Cancer Center | 2017-03-15 |
| Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies (NCT03082677) | Memorial Sloan Kettering Cancer Center | 2017-03-10 |
| Risk Stratification Among Individuals Who Have Many Moles on Their Skin (NCT03080948) | Memorial Sloan Kettering Cancer Center | 2017-03-09 |
| A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma (NCT03069378) | Memorial Sloan Kettering Cancer Center | 2017-03-03 |
| A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib (NCT03076164) | Memorial Sloan Kettering Cancer Center | 2017-03-01 |
| Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver (NCT03069950) | Memorial Sloan Kettering Cancer Center | 2017-02-28 |
| Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery (NCT03070340) | Memorial Sloan Kettering Cancer Center | 2017-02-28 |
| A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis (NCT03069326) | Memorial Sloan Kettering Cancer Center | 2017-02-27 |
| BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma (NCT03070327) | Memorial Sloan Kettering Cancer Center | 2017-02-27 |
| A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors (NCT03070301) | Memorial Sloan Kettering Cancer Center | 2017-02-27 |
| Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant (NCT03078010) | Memorial Sloan Kettering Cancer Center | 2017-02-10 |
| Investigation of the Effects of Electronic Cigarettes on Vascular Health (NCT03041493) | Memorial Sloan Kettering Cancer Center | 2017-02-01 |
| Assessing How Normal Variations in CT Scanning Affects Its Interpretation (NCT03038568) | Memorial Sloan Kettering Cancer Center | 2017-01-27 |
| A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) (NCT03033914) | Memorial Sloan Kettering Cancer Center | 2017-01-25 |
| Predicting Effective Therapy in Pancreatic Cancer (NCT03033927) | Memorial Sloan Kettering Cancer Center | 2017-01-24 |
| A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma (NCT03033303) | Memorial Sloan Kettering Cancer Center | 2017-01-23 |
| Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT03030885) | Memorial Sloan Kettering Cancer Center | 2017-01-19 |
| Study of Cognitive Behavioral Therapy for Insomnia (CBT-I) and Acupuncture for Insomnia and Related Distress Among Cancer Caregivers (NCT03012425) | Memorial Sloan Kettering Cancer Center | 2017-01-03 |
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer (NCT03015129) | Memorial Sloan Kettering Cancer Center | 2017-01-01 |
| Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma (NCT03026517) | Memorial Sloan Kettering Cancer Center | 2017-01-01 |
| A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer (NCT02989584) | Memorial Sloan Kettering Cancer Center | 2016-12-20 |
| Retrospective Review of Esophageal Cancer at MSKCC (NCT05706558) | Memorial Sloan Kettering Cancer Center | 2016-12-13 |
| Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In Vivo (NCT03004053) | Memorial Sloan Kettering Cancer Center | 2016-12-01 |
| Taxi STEP (Social Networks, Technology, and Exercise Through Pedometers) (NCT03010163) | Memorial Sloan Kettering Cancer Center | 2016-12-01 |
| Mobile Health Device Study for Myeloma Patients (NCT03006315) | Memorial Sloan Kettering Cancer Center | 2016-12-01 |
| Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer (NCT02954536) | Memorial Sloan Kettering Cancer Center | 2016-11-03 |
| Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma (NCT02974647) | Memorial Sloan Kettering Cancer Center | 2016-11-01 |
| Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer (NCT02962063) | Memorial Sloan Kettering Cancer Center | 2016-11-01 |
| PEACE: Comparing Chronic Pain Treatment Options (NCT02979574) | Memorial Sloan Kettering Cancer Center | 2016-11-01 |
| Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy (NCT02966730) | Memorial Sloan Kettering Cancer Center | 2016-11-01 |
| Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer (NCT02923570) | Memorial Sloan Kettering Cancer Center | 2016-10-03 |
| Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients (NCT02924324) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
| High Dose Carfilzomib for Newly Diagnosed Myeloma (NCT02937571) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
| Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment (NCT02932280) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
| Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma (NCT02921022) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
| Trial of YUMI Uterine Manipulator (NCT02923544) | Memorial Sloan Kettering Cancer Center | 2016-09-27 |
| Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study (NCT02928549) | Memorial Sloan Kettering Cancer Center | 2016-09-22 |
| Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers (NCT02928185) | Memorial Sloan Kettering Cancer Center | 2016-09-13 |
| A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers (NCT02910726) | Memorial Sloan Kettering Cancer Center | 2016-09-13 |
| Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet (NCT02902107) | Memorial Sloan Kettering Cancer Center | 2016-09-09 |
| Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant. (NCT02909036) | Memorial Sloan Kettering Cancer Center | 2016-09-01 |
| Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor (NCT02880293) | Memorial Sloan Kettering Cancer Center | 2016-08-23 |
| Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update (NCT06935071) | Memorial Sloan Kettering Cancer Center | 2016-08-04 |
| A Study to Assess Thymic Function Using PET/CT and MRI (NCT02909075) | Memorial Sloan Kettering Cancer Center | 2016-08-01 |
| A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing (NCT02895880) | Memorial Sloan Kettering Cancer Center | 2016-08-01 |
| Interest and Impact of Skin Cancer Genetic Testing (NCT02941900) | Memorial Sloan Kettering Cancer Center | 2016-08-01 |
| Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community (NCT02914899) | Memorial Sloan Kettering Cancer Center | 2016-08-01 |
| A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia (NCT02908061) | Memorial Sloan Kettering Cancer Center | 2016-08-01 |
| Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer (NCT02912767) | Memorial Sloan Kettering Cancer Center | 2016-07-20 |
| Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment (NCT02836093) | Memorial Sloan Kettering Cancer Center | 2016-07-13 |
| Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes (NCT02917798) | Memorial Sloan Kettering Cancer Center | 2016-07-12 |
| Sleep in Hospitalized Children at MSKCC (NCT02836041) | Memorial Sloan Kettering Cancer Center | 2016-07-07 |
| Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer (NCT02833883) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas (NCT02849171) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| Study of Abemaciclib in Dedifferentiated Liposarcoma (NCT02846987) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative Analysis (NCT02836535) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma (NCT02831686) | Memorial Sloan Kettering Cancer Center | 2016-07-01 |
| Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers (NCT02803203) | Memorial Sloan Kettering Cancer Center | 2016-06-29 |
| Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications (NCT02833246) | Memorial Sloan Kettering Cancer Center | 2016-06-28 |
| A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors (NCT02819843) | Memorial Sloan Kettering Cancer Center | 2016-06-21 |
| Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients (NCT02730130) | Memorial Sloan Kettering Cancer Center | 2016-06-03 |
| A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer (NCT02833233) | Memorial Sloan Kettering Cancer Center | 2016-06-01 |
| Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant (NCT02812082) | Memorial Sloan Kettering Cancer Center | 2016-06-01 |
| T-Cell Therapy for Advanced Breast Cancer (NCT02792114) | Memorial Sloan Kettering Cancer Center | 2016-06-01 |
| Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention (NCT02747160) | Memorial Sloan Kettering Cancer Center | 2016-06-01 |
| Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas (NCT02783625) | Memorial Sloan Kettering Cancer Center | 2016-05-23 |
| Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer (NCT02750358) | Memorial Sloan Kettering Cancer Center | 2016-05-19 |
| Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma (NCT02780310) | Memorial Sloan Kettering Cancer Center | 2016-05-19 |
| AASUR in High Risk Prostate Cancer (NCT02772588) | Memorial Sloan Kettering Cancer Center | 2016-05-12 |
| Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients (NCT02772367) | Memorial Sloan Kettering Cancer Center | 2016-05-11 |
| Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection (NCT02770326) | Memorial Sloan Kettering Cancer Center | 2016-05-10 |
| A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma (NCT02756247) | Memorial Sloan Kettering Cancer Center | 2016-05-09 |
| TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer (NCT02764333) | Memorial Sloan Kettering Cancer Center | 2016-05-06 |
| Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy. (NCT02909062) | Memorial Sloan Kettering Cancer Center | 2016-05-01 |
| Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) (NCT02836522) | Memorial Sloan Kettering Cancer Center | 2016-04-25 |
| Developing a New Questionnaire About Patient Expectations of Breast Conserving Therapy (NCT02753673) | Memorial Sloan Kettering Cancer Center | 2016-04-20 |
| A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer (NCT02737787) | Memorial Sloan Kettering Cancer Center | 2016-04-01 |
| A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE) (NCT02772575) | Memorial Sloan Kettering Cancer Center | 2016-04-01 |
| Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery (NCT02750319) | Memorial Sloan Kettering Cancer Center | 2016-04-01 |
| Lymphedema Surveillance Study (NCT02743858) | Memorial Sloan Kettering Cancer Center | 2016-04-01 |
| Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training (NCT02726763) | Memorial Sloan Kettering Cancer Center | 2016-03-30 |
| Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer (NCT02726399) | Memorial Sloan Kettering Cancer Center | 2016-03-18 |
| Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling (NCT02713334) | Memorial Sloan Kettering Cancer Center | 2016-02-25 |
| Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT02684253) | Memorial Sloan Kettering Cancer Center | 2016-02-11 |
| Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support (NCT02701829) | Memorial Sloan Kettering Cancer Center | 2016-02-01 |
| Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma (NCT02673333) | Memorial Sloan Kettering Cancer Center | 2016-02-01 |
| Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children (NCT02697396) | Memorial Sloan Kettering Cancer Center | 2016-02-01 |
| Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers (NCT02675829) | Memorial Sloan Kettering Cancer Center | 2016-02-01 |